Ferroptosis-related alternative splicing signatures as potential biomarkers for predicting prognosis and therapy response in gastric cancer
H1-99
0301 basic medicine
0303 health sciences
Science (General)
Prognosis
Social sciences (General)
Q1-390
Tumor microenvironment
Ferroptosis
Gastric cancer
Alternative splicing
Research Article
DOI:
10.1016/j.heliyon.2024.e34381
Publication Date:
2024-07-11T00:35:01Z
AUTHORS (9)
ABSTRACT
Ferroptosis is linked to various tumor biological traits, and alternative splicing (AS), a crucial step in mRNA processing, plays a role in the post-transcriptional regulation of ferroptosis-related genes (FRGs). A least absolute shrinkage and selection operator (LASSO) penalized Cox regression analysis was utilized to build a prognostic signature based on 12 AS events (p < 0.05), which was validated in gastric cancer (GC) patients. The high-risk group (n = 203) showed enrichment in cancer and metastasis pathways (p < 0.05). Significant differences existed between the high- and low-risk groups in terms of tumor microenvironment (TME) cell infiltration and immune activities (p < 0.05). The low-risk group (n = 203) was characterized by immune activation and improved prognosis (p < 0.001). Additionally, targeted treatment and immunotherapy were more likely to benefit the low-risk group (p < 0.05). Correlation analysis was performed to detect related splicing factors (SF) (Cor>0.4, FDR<0.05). Furthermore, our functional assay results suggested that high SF3A2 expression might increase ferroptosis resistance and promote cell proliferation. In conclusion, the FRAs model we built has an advantage in predicting GC prognosis. The model's demonstration of variations in the immune microenvironment and drug response could potentially inform decisions regarding treatment strategies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (60)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....